iShares US Pharmaceuticals ETF
IHE
IHE
108 hedge funds and large institutions have $285M invested in iShares US Pharmaceuticals ETF in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 37 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $317M → $285M (-$32M)
35% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 37
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
108
Holding in Top 10
1
Calls
$540K
Puts
$247K
Top Buyers
| 1 | +$8.2M | |
| 2 | +$5.2M | |
| 3 | +$660K | |
| 4 |
TC
Telemus Capital
Southfield,
Michigan
|
+$500K |
| 5 |
TFF
The Family Firm
Bethesda,
Maryland
|
+$271K |
Top Sellers
| 1 | -$7.54M | |
| 2 | -$6.49M | |
| 3 | -$6.07M | |
| 4 |
RTS
Round Table Services
Westfield,
New Jersey
|
-$5.45M |
| 5 |
Morgan Stanley
New York
|
-$3.25M |